NCT06679296 · RECRUITING

Study on Aging and Cognitive Impairment in China

This is a large observational study in China tracking how people of all ages — from children to elderly — develop or avoid cognitive decline over time. Researchers are collecting medical exams, brain scans, blood tests, and psychological assessments to build a database on aging and cognition. No phase is listed because this is not a drug trial — it is a longitudinal cohort study, meaning it follows people over time to spot patterns and risk factors.

You may qualify if

  • Ability to sign an informed consent form: Participants and/or their legally authorized representatives, in case of diminished decision-making capacity, are capable of reading, understanding, and providing written informed consent as per national legal requirements.
  • Capability to complete assessments independently or with assistance.
  • Willingness and ability to fulfill all study requirements, including peripheral organ function assessments, EEG, lumbar puncture, MRI, and PET imaging examinations.
  • Agreement to participate in follow-up visits.

You're excluded if

  • Terminal stage of significant diseases such as malignant tumors or autoimmune diseases at enrollment;
  • Substance abusers.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-11-07

View full record on ClinicalTrials.gov

All APOE4 clinical trials